Скачать или смотреть First Ever Malaria Medicine Approved for Newborns: Coartem Baby Breakthrough

For the first time ever, a medication specially formulated for newborns and infants has been approved to treat malaria.

Coartem Baby, a dissolvable, cherry-flavored treatment developed by Novartis in collaboration with the Medicines for Malaria Venture, has received approval from Swissmedic — offering hope to some of the world’s most vulnerable populations: newborns weighing under 11 pounds.

Malaria remains one of the deadliest diseases affecting children under five, especially in sub-Saharan Africa. Until now, there were limited safe and effective treatment options for newborns. Coartem Baby changes that by providing a child-friendly, easy-to-administer medication that can save thousands of young lives.

In this video, we explore:

What Coartem Baby is and how it works

The significance of this breakthrough for global health

Why this medication is a game-changer for malaria treatment in infants

The impact on families and communities fighting malaria worldwide

This is a monumental step forward in protecting newborns from malaria and moving closer to a malaria-free future.

Don’t forget to like, subscribe, and share to spread this important news!

#Malaria #NewbornHealth #CoartemBaby #MedicalBreakthrough #GlobalHealth #InfantCare #MalariaTreatment